<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000509038">
  <TermName>romidepsin</TermName>
  <TermPronunciation>(ROH-mih-DEP-sin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat adults with cutaneous T-cell lymphoma that has already been treated with at least one other type of systemic therapy.  It is also being studied in the treatment of other types of cancer. Romidepsin blocks certain enzymes needed for cell division and may kill cancer cells. It is a type of depsipeptide and a type of histone deacetylase inhibitor. Also called FR901228 and Istodax.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718512" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;romidepsin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718513" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;romidepsina&quot;" language="es" id="_4"/>
  <SpanishTermName>romidepsina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para el tratamiento de adultos con linfoma cutáneo de células T para el que ya recibieron por lo menos otro tipo de terapia sistémica. También está en estudio para el tratamiento de
otros tipos de cáncer. La romidepsina bloquea ciertas enzimas necesarias para la división celular y es posible que destruya células cancerosas. Es un tipo de depsipéptido
y de inhibidor de la histona–desacetilasa. También se llama FR901228 e Istodax.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-09-15</DateFirstPublished>
  <DateLastModified>2021-09-29</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000659493" url="/about-cancer/treatment/drugs/romidepsin">Romidepsin</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
